MOG and encephalitis: Although anti-MOG antibody titers can vary among patients with overlapping encephalitis, the response to steroid treatment and high relapse rates in this condition are challenging to attribute to the clinical phenotype exhibited by anti-NMDAR antibodies and are similar to the clinical features of MOGAD (10, 20, 26).